Small Pharma Inc.
DMTTF · OTC
2/28/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | – | – | 100% | – |
| R&D Expenses | $0 | $0 | $0 | – |
| G&A Expenses | $0 | $0 | $0 | – |
| SG&A Expenses | $0 | $0 | $0 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $0 | $0 | $0 | – |
| Operating Expenses | $0 | $0 | $0 | – |
| Operating Income | -$0 | -$0 | -$0 | – |
| % Margin | – | – | -7,239.6% | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | – |
| Pre-Tax Income | -$0 | -$0 | -$0 | – |
| Tax Expense | -$0 | -$0 | $0 | – |
| Net Income | -$0 | -$0 | -$0 | – |
| % Margin | – | – | -9,061.1% | – |
| EPS | -0.071 | -0.072 | -0.022 | – |
| % Growth | 0.7% | -222.1% | – | – |
| EPS Diluted | -0.071 | -0.072 | -0.022 | – |
| Weighted Avg Shares Out | 0 | 0 | 0 | – |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $0 | $0 | $0 | – |
| EBITDA | -$0 | -$0 | -$0 | – |
| % Margin | – | – | -12,447.8% | – |